These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4620108)

  • 21. The agent of trachoma. Recent studies of the biology, biochemistry and immunology of a prokaryotic obligate parasite of eukaryocytes.
    Becker Y
    Monogr Virol; 1974; 7():1-99. PubMed ID: 4364815
    [No Abstract]   [Full Text] [Related]  

  • 22. Prototype misidentification makes conclusions about pathotype growth characteristics uncertain.
    Schachter J; Dawson CR
    J Infect Dis; 2007 Jan; 195(2):307-8; author reply 308-9. PubMed ID: 17191180
    [No Abstract]   [Full Text] [Related]  

  • 23. Laboratory tests for chlamydial infection. Their role in epidemiological studies of trachoma and its control.
    Jones BR
    Br J Ophthalmol; 1974 Apr; 58(4):438-54. PubMed ID: 4606714
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of Chlamydia trachomatis pooled serotypes BDE and FGK in children with chronic follicular conjunctivitis.
    Sirmatel F; Oguz H
    Jpn J Ophthalmol; 2000; 44(5):467-9. PubMed ID: 11033122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trachoma vaccine field trials in The Gambia.
    Sowa S; Sowa J; Collier LH; Blyth WA
    J Hyg (Lond); 1969 Dec; 67(4):699-717. PubMed ID: 5261212
    [No Abstract]   [Full Text] [Related]  

  • 26. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys.
    Wang SP; Grayston JT
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1133-45. PubMed ID: 4960878
    [No Abstract]   [Full Text] [Related]  

  • 27. [Follicular conjunctivitis due to Chlamydia trachomatis].
    Basualdo JA; Huarte L; Bautista E; Niedfeld G; Alfonso G; Rosso N; Geronés M; Galeppi I
    Medicina (B Aires); 2001; 61(4):397-400. PubMed ID: 11563166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the fluorescent and precipitating agglutinating antibodies of the causative agent of trachoma (Chlamydia trachomatis) in the PLT group].
    Haider F; Dodin A; Capponi M
    C R Seances Soc Biol Fil; 1970; 164(1):105-9. PubMed ID: 4248009
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevalence of the Chlamydia trachomatis in neonatal conjunctivitis determination by indirect fluorescence and gene amplification].
    Valencia C; Prado V; Ríos M; Cruz MA; Pilorget JJ
    Rev Med Chil; 2000 Jul; 128(7):758-65. PubMed ID: 11050837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Present-day characteristics of diagnosis of trachoma].
    Shatkin AA; Nurmamedov NN; Tarasova LN; Tsereteli EK
    Vestn Oftalmol; 1975; (5):72-5. PubMed ID: 798392
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chlamydia trachomatis in conjunctival specimens].
    Dereli D; Ertem E; Serter D; Köse S; Haznedaroğlu G
    Mikrobiyol Bul; 1993 Apr; 27(2):127-30. PubMed ID: 8502183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of TRIC agent (Chlamydia) in irradiated McCoy cell culture from endemic trachoma in field studies in Iran. Comparison with other laboratory tests for detection of Chlamydia.
    Darougar S; Treharne JD; Dwyer RS; Kinnison JR; Jones BR
    Br J Ophthalmol; 1971 Sep; 55(9):591-9. PubMed ID: 4106450
    [No Abstract]   [Full Text] [Related]  

  • 33. An evaluation of the fluorescent antibody technic in the diagnosis of trachoma and inclusion conjunctivitis.
    Hanna L
    Rev Int Trach; 1968; 45(4):345-59. PubMed ID: 4923444
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recurrent canaliculitis and dacryocystitis as a sequela of persistent infection with Chlamydia trachomatis].
    Janssen K; Gerding H; Busse H
    Ophthalmologe; 1993 Feb; 90(1):17-20. PubMed ID: 8443442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species-specific antigens from trachoma and inclusion-conjuctivitis (chlamydial) agents.
    Vedros NA
    J Immunol; 1967 Dec; 99(6):1183-6. PubMed ID: 6060969
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic test in trachoma: putting in place a study model and preliminary results].
    Chamoiseau G; Chassot P; Le Jan C; Pull J
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1989; 66(1-2):21-9. PubMed ID: 2700505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three new immunologic types of trachoma-inclusion conjunctivitis organisms.
    Wang SP; Grayston JT; Gale JL
    J Immunol; 1973 Mar; 110(3):873-9. PubMed ID: 4631875
    [No Abstract]   [Full Text] [Related]  

  • 38. Serotypes of trachoma agent isolated in the Gambia: with an observation on the relation between serotype and morphology.
    Sowa J; Collier LH; Sowa S
    J Hyg (Lond); 1974 Jun; 72(3):389-95. PubMed ID: 4135585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of Chlamydial particles using direct immunofluorescence in ambulatory ophthalmologic practice].
    Bartovic V; Botek R; Gavorník P; Kristofovicová A; Melichácová V
    Cesk Slov Oftalmol; 2002 Nov; 58(6):412-7. PubMed ID: 12629858
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of Chlamydia trachomatis in the etiology of conjunctivitis].
    Szymulska M; Zagórski Z
    Klin Oczna; 1995; 97(3-4):64-5. PubMed ID: 7474795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.